Validation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay with Genital Swabs and Breast Milk Samples
Open Access
- 1 November 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (11) , 3929-3937
- https://doi.org/10.1128/jcm.40.11.3929-3937.2002
Abstract
Human immunodeficiency type 1 (HIV-1) continues to spread at an alarming rate. The virus may be transmitted through blood, genital secretions, and breast milk, and higher levels of systemic virus in the index case, as measured by plasma RNA viral load, have been shown to correlate with increased risk of transmitting HIV-1 both vertically and sexually. Less is known about the correlation between transmission and HIV-1 levels in breast milk or genital secretions, in part because reliable quantitative assays to detect HIV-1 in these fluids are not available. Here we show that the Gen-Probe HIV-1 viral load assay can be used to accurately quantify viral load in expressed breast milk and in cervical and vaginal samples collected on swabs. Virus could be quantified from breast milk and swab samples spiked with known amounts of virus, including HIV-1 subtypes A, C, and D. As few as 10 copies of HIV-1 RNA could be detected above background threshold levels in ≥77% of assays performed with spiked breast milk supernatants and mock swabs. In genital swab samples from HIV-1-infected women, similar levels of HIV-1 RNA were consistently detected in duplicate swabs taken from the same woman on the same clinic visit, suggesting that the RNA values from a single swab sample can be used to measure genital viral load.Keywords
This publication has 20 references indexed in Scilit:
- The Effect of Treatment of Vaginal Infections on Shedding of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 2001
- Correlates of Mother‐to‐Child Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission: Association with Maternal Plasma HIV‐1 RNA Load, Genital HIV‐1 DNA Shedding, and Breast InfectionsThe Journal of Infectious Diseases, 2001
- Short‐Course Antenatal Zidovudine Reduces Both Cervicovaginal Human Immunodeficiency Virus Type 1 RNA Levels and Risk of Perinatal TransmissionThe Journal of Infectious Diseases, 2000
- Maternal Virus Load and Perinatal Human Immunodeficiency Virus Type 1 Subtype E Transmission, ThailandThe Journal of Infectious Diseases, 1999
- Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive womenObstetrics & Gynecology, 1997
- Timing of maternal-infant HIV transmissionAIDS, 1997
- The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Shedding of HIV-1 in the genital tractAIDS, 1996
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996
- Genetic variability of HIV-1AIDS, 1996